Cyclotide & Antibody libraries for drug discovery & delivery
Cyclogenix is a UK-based biotech focused on the development of novel biotherapeutics with wide-ranging expertise in cyclotide-based drug delivery systems and antibody engineering.
Having successfully attracted funding from large Pharmaceutical companies, venture groups and public agencies, our main interests for research and development currently are:
- Human Antibody Engineering
- VNAR Antibody Agents
- Cyclic Peptide Applications
- Biotherapeutic Delivery & Disease Targeting
Discovery Services
We currently have vast antibody and peptide libraries for research and pre-clinical studies, designed research molecular tools for cell penetration, bespoke cyclobodies to internalise your specific cargoes and highly stable IgNAR libraries.
Human Antibody Discovery Services
vast libraries available
Cyclogenix' phage display libraries contain over 70 billion distinct fully human antibodies.
View detail
VNAR Antibody Discovery Services
stable Ab conjugates
VNARs are highly small (10kDa), soluble and stable immunoglobulin-like domains which demonstrate unique binding characteristics...
View detail
Cyclic Peptide Discovery Services
peptide design
"Loop replacement" libraries - with over 50 billion unique clones)...
View detail
Biotherapuetic Delivery Services
membrane and BBB traversal
Applications of cyclotides/cyclobodies in drug/peptide and protein delivery across membranes...
View detail